Dr. Umur S. Hatipoglu, MD

Dr. Hatipoglu practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Hatipoglu's NPI, 1720073612, was assigned on September 16, 2005. Dr. Hatipoglu graduated from Istanbul University Fom in 1992. Dr. Hatipoglu holds Ohio license 35092002.

Dr. Hatipoglu's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Hatipoglu's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Hatipoglu is also affiliated with Fairview Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Hatipoglu to 1 more hospital and 2 clinical labs, each named with a free account. Dr. Hatipoglu's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hatipoglu practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Hatipoglu's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Hatipoglu is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Hatipoglu's licenses on file in 2 states: Ohio and Illinois.

Dmand AI lists acute respiratory failure, asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, hypersomnia, pneumonia and pulmonary fibrosis among the conditions Dr. Hatipoglu treats.

CMS data shows 359 Medicare services from Dr. Hatipoglu across 7 procedure codes in 2024, for 186 Medicare patients. Medicare paid $38,493 for them.

CMS counts 186 Medicare patients who saw Dr. Hatipoglu in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hatipoglu's median patient age at 65, with 52% women.

In 2024, Dr. Hatipoglu wrote 1,269 Medicare Part D claims for 145 patients. 43% of them were for generic drugs. CMS names the drug for 1,186 of them, across 30 drugs with 11 or more claims each, at $539,140 in total drug cost. In 2023, CMS named 1,137 claims across 26 drugs.

Dr. Hatipoglu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hatipoglu as offering telehealth.

Dmand AI links 13 papers to Dr. Hatipoglu, published from 2012 to 2020. 2019 was the busiest year, with 2. The most frequent topics are COVID-19, Pulmonary Disease, Chronic Obstructive and Respiration, Artificial. Dr. Hatipoglu has published most often in BMJ Case Rep. Dr. Hatipoglu's most frequent co-authors are Abhijit Duggal, MD, MPH, MS, Sudhir Krishnan, MD and Atul C. Mehta.

Dmand AI links Dr. Hatipoglu to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Pulmonary Disease, Chronic Obstructive, Lung Diseases, Obstructive and Smoking. University of Minnesota sponsors the most, 2.

CMS Open Payments shows 14 general payments to Dr. Hatipoglu from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. Genentech, Inc. paid the most, $6,447.

Dr. Hatipoglu graduated from Istanbul University Fom in 1992.

Dr. Hatipoglu is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.